Unfolded Protein Response

Unfolded Protein Response (UPR)

The Unfolded Protein Response (UPR) is a critical cellular stress response mechanism that detects and resolves endoplasmic reticulum (ER) stress caused by misfolded protein accumulation. The UPR plays a significant role in [neurodegenerative diseases](/diseases/alzheimers-disease) including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [ALS](/diseases/als), where protein misfolding and ER stress are central pathological features.

Overview

The UPR is mediated by three ER transmembrane sensors: [IRE1](/proteins/ire1-protein), [PERK](/proteins/perk-protein), and [ATF6](/proteins/atf6-protein). These sensors normally bind to [BiP](/proteins/grp78-protein) (GRP78), an ER chaperone, but are released when misfolded proteins accumulate in the ER lumen[@walter2011].

UPR Branches

| Sensor | Domain | Primary Effect |
|--------|--------|----------------|
| [IRE1](/proteins/ire1-protein) | Kinase + RNase | XBP1 splicing → chaperone expression |
| [PERK](/proteins/perk-protein) | Kinase | eIF2α phosphorylation → translation attenuation |
| [ATF6](/proteins/atf6-protein) | Transcription factor | Cleavage → transcription factor activation |

Role in Neurodegeneration

Alzheimer's Disease

Unfolded Protein Response (UPR)

The Unfolded Protein Response (UPR) is a critical cellular stress response mechanism that detects and resolves endoplasmic reticulum (ER) stress caused by misfolded protein accumulation. The UPR plays a significant role in [neurodegenerative diseases](/diseases/alzheimers-disease) including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [ALS](/diseases/als), where protein misfolding and ER stress are central pathological features.

Overview

The UPR is mediated by three ER transmembrane sensors: [IRE1](/proteins/ire1-protein), [PERK](/proteins/perk-protein), and [ATF6](/proteins/atf6-protein). These sensors normally bind to [BiP](/proteins/grp78-protein) (GRP78), an ER chaperone, but are released when misfolded proteins accumulate in the ER lumen[@walter2011].

UPR Branches

| Sensor | Domain | Primary Effect |
|--------|--------|----------------|
| [IRE1](/proteins/ire1-protein) | Kinase + RNase | XBP1 splicing → chaperone expression |
| [PERK](/proteins/perk-protein) | Kinase | eIF2α phosphorylation → translation attenuation |
| [ATF6](/proteins/atf6-protein) | Transcription factor | Cleavage → transcription factor activation |

Role in Neurodegeneration

Alzheimer's Disease

In [Alzheimer's disease](/diseases/alzheimers-disease), UPR activation occurs early and contributes to both protective and pathological processes:

• Adaptive Response: UPR upregulates chaperone proteins like [BiP](/proteins/grp78-protein) and protein disulfide isomerase to enhance [ER folding capacity](/mechanisms/protein-folding)
• Pro-apoptotic Signaling: Chronic ER stress triggers [CHOP](/proteins/chop-protein) expression, leading to [neuronal apoptosis](/mechanisms/neuronal-death-ad)
• Synaptic Dysfunction: UPR affects synaptic protein synthesis and trafficking
• Relations to Key Proteins: UPR interacts with [APP](/genes/app) processing and [amyloid-beta](/proteins/amyloid-beta) toxicity

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease), UPR is activated by:

• [Alpha-synuclein](/proteins/alpha-synuclein) misfolding and aggregation
• [LRRK2](/proteins/lrrk2-protein) mutations causing ER stress
• [PARKIN](/proteins/parkin) and [PINK1](/proteins/pink1-protein) dysfunction affecting mitochondrial protein quality control
• Dopaminergic neuron vulnerability to ER stress

Amyotrophic Lateral Sclerosis (ALS)

[ALS](/diseases/als) involves:

• [SOD1](/proteins/sod1-protein) mutations causing protein misfolding
• [TDP-43](/proteins/tdp-43) aggregation triggering ER stress
• [C9orf72](/genes/c9orf72) hexanucleotide repeat expansions leading to RNA toxicity and ER dysfunction
• Motor neuron-specific vulnerability to prolonged UPR activation

Other Neurodegenerative Disorders

• [Huntington's Disease](diseases/huntingtons): Mutant [huntingtin protein](/proteins/huntingtin) causes ER stress
• [Prion Diseases](/diseases/prion-disease): Misfolded prion protein triggers UPR
• [Frontotemporal Dementia](/diseases/frontotemporal-dementia): [Tau](/proteins/tau) and [TDP-43](/proteins/tdp-43) pathology associated with UPR

Molecular Mechanisms

IRE1-XBP1 Pathway

The [IRE1](/proteins/ire1-protein) pathway orchestrates the adaptive UPR:

PERK-eIF2α Pathway

The [PERK](/proteins/perk-protein) pathway mediates translational control:

ATF6 Activation

[ATF6](/proteins/atf6-protein) activation involves:

Intersection with Other Pathways

Mitochondrial Dysfunction

The UPR intersects with [mitochondrial protein quality control](/mechanisms/mitochondrial-dysfunction-ad):

• [PINK1](/proteins/pink1-protein) and [PARKIN](/proteins/parkin) mitophagy pathways
• Mitochondrial UPR (mtUPR) signaling
• Cross-talk between ER and mitochondrial stress responses

Autophagy

[Autophagy](/mechanisms/autophagy-lysosome-neurodegeneration) and UPR are interconnected:

• ER stress can induce [autophagy](/entities/autophagy)
• Autophagy helps clear misfolded proteins
• IRE1-JNK signaling promotes autophagy

Neuroinflammation

[Neuroinflammation](/mechanisms/neuroinflammation) in neurodegeneration involves:

• [Microglial](/cell-types/microglia) activation by UPR-related stress signals
• [NF-κB](/entities/nf-kb) pathway cross-talk
• Cytokine release and neuroinflammation amplification

Oxidative Stress

[Reactive oxygen species](/entities/reactive-oxygen-species) and UPR:

• ER stress generates ROS
• Oxidative stress exacerbates protein misfolding
• Antioxidant responses intersect with UPR signaling

Therapeutic Targets

Small Molecule Modulators

| Compound | Target | Status |
|----------|--------|--------|
| [ISRIB](/therapeutics/isrib) | eIF2α/GBE | Research phase |
| [TUDCA](/therapeutics/tudca) | General UPR mod | Clinical trials |
| [Sodium phenylbutyrate](/therapeutics/sodium-phenylbutyrate) | [HDAC](/entities/hdac-enzymes) inhibitor/UPR | FDA approved for other uses |
| [Guanabenz](/therapeutics/guanabenz) | eIF2α phosphatase | Research phase |

Gene Therapy Approaches

• [XBP1](/proteins/xbp1-protein) gene therapy
• [CHOP](/proteins/chop-protein) knockdown
• [ATF6](/proteins/atf6-protein) activation
• [BiP](/proteins/grp78-protein) overexpression

Natural Compounds

• [Curcumin](/therapeutics/curcumin): ER stress modulator
• [Resveratrol](/therapeutics/resveratrol): SIRT1 activation and UPR effects
• [Epigallocatechin gallate](/therapeutics/egcg): Protein aggregation and ER stress

Biomarkers

UPR Activity Markers

• [BiP](/proteins/grp78-protein) levels
• [XBP1](/proteins/xbp1-protein) splicing
• CHOP expression
• p-eIF2α levels

Clinical Relevance

UPR markers in [cerebrospinal fluid](/mechanisms/cerebrospinal-fluid) and blood may serve as:

• Disease progression biomarkers
• Therapeutic response indicators
• Early diagnostic markers

See Also

• [ER Stress](/mechanisms/er-stress)
• [Protein Misfolding](/mechanisms/protein-aggregation)
• [Alzheimer's Disease Mechanisms](/mechanisms/alzheimers-disease/pathology)
• [Parkinson's Disease Mechanisms](/mechanisms/parkinsons-disease/pathology)
• [Neuroprotection](/mechanisms/neuroprotection)

External Links

• [Allen Human Brain Atlas](https://brain-map.org/)

References

Pathway Diagram

Pathway Diagram

The following diagram shows the key molecular relationships involving Unfolded Protein Response discovered through SciDEX knowledge graph analysis: